Hematopoietic Cell Transplantation Recipient
Showing 1 - 16 of 16
Participated in Children's Oncology Group Studies
Recruiting
- Acute Lymphoblastic Leukemia
- +5 more
- Assessment of Therapy Complications
- Questionnaire Administration
-
Birmingham, Alabama
- +163 more
Sep 6, 2022
Hematopoietic Cell Transplantation Recipient, Refractory B-Cell Non-Hodgkin Lymphoma, Refractory Hodgkin Lymphoma Trial in
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +3 more
- Allogeneic Bone Marrow Transplantation
- +10 more
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (Ixazomib Citrate, Lenalidomide,
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- Plasma Cell Myeloma
- Ixazomib Citrate
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Mar 8, 2022
Acute Lymphoblastic Leukemia, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid Leukemia Trial in Duarte (drug, other,
Recruiting
- Acute Lymphoblastic Leukemia
- +7 more
- Fludarabine
- +3 more
-
Duarte, CaliforniaCity of Hope Medical Center
Feb 17, 2022
Bone Marrow Transplantation Recipient, Cord Blood Transplant Recipient, Hematopoietic Cell Transplantation Recipient Trial in
Active, not recruiting
- Bone Marrow Transplantation Recipient
- +2 more
- Eltrombopag Olamine
- Laboratory Biomarker Analysis
-
Houston, TexasM D Anderson Cancer Center
Feb 9, 2022
Hematopoietic Cell Transplantation Recipient, Plasma Cell Myeloma Trial in Houston (biological, drug, other)
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- Plasma Cell Myeloma
- Elotuzumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Feb 2, 2022
Benign Tumor, Bone Marrow Transplantation Recipient, Hematopoietic Cell Transplantation Recipient Trial in Portland (Bone Marrow
Available
- Benign Neoplasm
- +3 more
- Bone Marrow Transplantation
- +2 more
-
Portland, OregonOHSU Knight Cancer Institute
Dec 9, 2021
Hematopoietic Cell Transplantation Recipient, Recurrent DLBCL, Recurrent Grade 1 Follicular Lymphoma Trial in Columbus
Active, not recruiting
- Hematopoietic Cell Transplantation Recipient
- +11 more
- Carmustine
- +5 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Sep 29, 2021
GVHD, Hematopoietic Cell Transplantation Recipient Trial in New Brunswick (Dietary Intervention, Laboratory Biomarker Analysis)
Terminated
- Graft Versus Host Disease
- Hematopoietic Cell Transplantation Recipient
- Dietary Intervention
- Laboratory Biomarker Analysis
-
New Brunswick, New JerseyRutgers Cancer Institute of New Jersey
Aug 20, 2021
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Palo Alto (Ibrutinib, Laboratory
Unknown status
- Acute Biphenotypic Leukemia
- +4 more
- Ibrutinib
- Laboratory Biomarker Analysis
-
Palo Alto, CaliforniaStanford University, School of Medicine
Jan 28, 2021
Acute Leukemia in Remission, Hematopoietic Cell Transplantation Recipient, Lymphoma Trial in Seattle (Monitoring Device,
Completed
- Acute Leukemia in Remission
- +2 more
- Monitoring Device
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Sep 8, 2020
Hematopoietic Cell Transplantation Recipient Trial in Seattle (Booklet, Exercise Intervention, Quality-of-Life Assessment)
Completed
- Hematopoietic Cell Transplantation Recipient
- Booklet
- +4 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Mar 2, 2020
Hematopoietic Cell Transplantation Recipient, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Columbus
Withdrawn
- Hematopoietic Cell Transplantation Recipient
- +2 more
- Laboratory Biomarker Analysis
- +2 more
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Feb 19, 2020
Acute Biphenotypic Leukemia, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia Trial in Seattle (Platelet Transfusion)
Terminated
- Acute Biphenotypic Leukemia
- +13 more
- Platelet Transfusion
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Oct 17, 2019
Hematopoietic and Lymphoid Cell Tumor, Hematopoietic Cell Transplantation Recipient Trial in Duarte (procedure, drug, other,
Withdrawn
- Hematopoietic and Lymphoid Cell Neoplasm
- Hematopoietic Cell Transplantation Recipient
- Allogeneic Hematopoietic Stem Cell Transplantation
- +8 more
-
Duarte, CaliforniaCity of Hope Medical Center
Dec 5, 2018
Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive, Acute Lymphoblastic Leukemia in Remission, Acute Myeloid
Withdrawn
- Accelerated Phase Chronic Myelogenous Leukemia, BCR-ABL1 Positive
- +11 more
- Multi-antigen CMV-Modified Vaccinia Ankara Vaccine
- +2 more
-
Duarte, California
- +2 more
Nov 19, 2018